1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Head and Neck Carcinoma, Squamous Cell: new trials by email Literature Review of Head and Neck Carcinoma, Squamous Cell trials Research Report on Head and Neck Carcinoma, Squamous Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors TAK-659, Nivolumab - Triple-Negative Breast Neoplasms, Carcinoma, Non-Small-Cell Lung | Phase 1 | Terminated | Calithera Biosciences, Inc | 41 | 2016-08-12 | 2023-02-08 |
Carcinoma, Non-Small-Cell Lung (1) · Squamous Cell Carcinoma of Head and Neck (1) · Triple Negative Breast Neoplasms (1)
Breast Diseases (1) · Breast Neoplasms (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1)
Calithera Biosciences, Inc (1)
Italy (1) · Spain (1) · United Kingdom (1) · United States (1)
2016 (1)